Altman Peter

Altman Peter, President and CEO, has demonstrated a consistent pattern of insider buying activity in BioCardia, Inc. (BCDA) based on SEC Form 4 filings. Over 41 reported transactions, Altman has exclusively purchased shares, with no recorded sales, totaling $475,297.27 in aggregate value. This trend underscores a strong bias toward accumulating BCDA stock, signaling confidence in the company’s prospects. Notably, 22 of these transactions occurred recently, with purchases ranging from modest amounts, such as $183 on August 13, 2025, to significant investments, including $60,000 on September 19, 2025, and $49,998.63 on April 23, 2025. The most recent transactions, spanning March 2026, further highlight this pattern, with purchases of $366 on March 25, $744 on March 24, and $5,650 on February 4, 2026. These acquisitions, combined with earlier activity, suggest a sustained commitment to increasing his stake in BCDA. Altman’s trading activity is characterized by frequent, incremental purchases, often clustered around specific dates, such as multiple transactions in May 2025 and April 2025. This approach indicates a deliberate strategy of accumulating shares over time rather than sporadic or isolated investments. The absence of any selling activity reinforces the narrative of long-term confidence in the company’s trajectory.